1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early-onset pancreatic ductal adenocarcinoma (PDAC) at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Kunte, S.; Sangli, S.; Lemor, A.; Lowery, M. A.; Yu, K. H.; Abou-Alfa, G. K.; Varghese, A. M.; O'Reilly, E. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406)
    Meeting Abstract

    Kopetz, S.; McDonough, S. L.; Lenz, H. J.; Magliocco, A. M.; Atreya, C. E.; Diaz, L. A.; Allegra, C. J.; Raghav, K. P. S.; Morris, V. K.; Wang, S. E.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Correlation of benefit from immune checkpoint inhibitors with next gen sequencing (NGS) profiles in esophagogastric cancer (EGC) patients
    Meeting Abstract

    Ku, G. Y.; Sanchez-Vega, F.; Chatila, W.; Margolis, M.; Fein, C.; Ilson, D. H.; Hechtman, J. F.; Tuvy, Y.; Bouvier, N.; Kundra, R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase I/II study of durvalumab and tremelimumab in patients with unresectable hepatocellular carcinoma (HCC): Phase I safety and efficacy analyses
    Meeting Abstract

    Kelley, R. K.; Abou-Alfa, G. K.; Bendel, J. C.; Kim, T. Y.; Borad, M. J.; Yong, W. P.; Morse, M.; Kang, Y. K.; Rebelatto, M.; Makowsky, M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Retrospective review of subsequent treatments (tx) for esophagogastric adenocarcinomas (EGA) refractory to FOLFOX
    Meeting Abstract

    Kelly, C. M.; Janjigian, Y. Y.; Kelsen, D. P.; Capanu, M.; Chou, J. F.; Ilson, D. H.; Ku, G. Y.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical and genomic alterations features of patients with advanced colitis associated cancers (CAC)
    Meeting Abstract

    Kelsen, D. P.; Miller, V. A.; Tang, L. H.; Capanu, M.; Balasubramanian, S.; Ross, J. S.; Stephens, P. J.; Yaeger, R.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Alliance for clinical trials in oncology trial A021501: Preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas
    Meeting Abstract

    Katz, M. H. G.; Ou, F. S.; Herman, J.; Ahrnad, S. A.; Wolpin, B. M.; Marsh, R. D.; Shi, Q.; Hubbard, J. M.; Meyerhardt, J. A.; Chuang, M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Brain metastases (BM) in pancreatic ductal adenocarcinoma (PDAC): Clinical and molecular characteristics
    Meeting Abstract

    Jordan, E.; Kaley, T. J.; Capanu, M.; Estrella, H.; Leach, S. D.; Basturk, O.; Klimstra, D. S.; Allen, P. J.; Berger, M. F.; Yu, K. H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Two randomized, placebo-controlled phase 3 studies of ruxolitinib (Rux) + capecitabine (C) in patients (pts) with advanced/metastatic pancreatic cancer (mPC) after failure/intolerance of first-line chemotherapy: JANUS 1 (J1) and JANUS 2 (J2)
    Meeting Abstract

    Hurwitz, H.; Van Cutsem, E.; Bendell, J. C.; Hidalgo, M.; Li, C. P.; Garrido, M.; Macarulla, T. M.; Sahai, V.; Sama, A. R.; Greeno, E.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical characterization of pancreatic ductal adenocarcinomas (PDAC) with mismatch repair (MMR) gene mutations
    Meeting Abstract

    Hu, Z. I.; Varghese, A. M.; Shia, J.; Zervoudakis, A.; Lowery, M. A.; Yu, K. H.; Chalasani, S. B.; Robson, M. E.; Stadler, Z. K.; Caron, P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save